• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak.

作者信息

Kardas Przemyslaw, van Boven Job Frank Martien, Pinnock Hilary, Menditto Enrica, Wettermark Björn, Tsiligianni Ioanna, Ágh Tamás

机构信息

Medication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Narutowicza St. 60, 90-136 Lodz, Poland.

Department of Clinical Pharmacy & Pharmacology, Medication Adherence Expertise Center of the northern Netherlands (MAECON), University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.

出版信息

Lancet Reg Health Eur. 2021 May;4:100099. doi: 10.1016/j.lanepe.2021.100099. Epub 2021 Apr 14.

DOI:10.1016/j.lanepe.2021.100099
PMID:33875981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8046426/
Abstract
摘要

相似文献

1
Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak.欧洲医疗体系在新冠疫情期间维持非传染性疾病药物治疗连续性的方法差异。
Lancet Reg Health Eur. 2021 May;4:100099. doi: 10.1016/j.lanepe.2021.100099. Epub 2021 Apr 14.
2
The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.COVID-19 疫情对欧洲非传染性疾病患者的潜在长期影响：对健康老龄化的影响。
Aging Clin Exp Res. 2020 Jul;32(7):1189-1194. doi: 10.1007/s40520-020-01601-4. Epub 2020 May 26.
3
Working in the era of COVID-19: An organization model for maxillofacial surgery based on telemedicine and video consultation.在 COVID-19 时代工作：基于远程医疗和视频咨询的颌面外科组织模式。
J Craniomaxillofac Surg. 2021 Apr;49(4):323-328. doi: 10.1016/j.jcms.2021.01.027. Epub 2021 Feb 5.
4
Assessment of Healthcare System Capabilities and Preparedness in Yemen to Confront the Novel Coronavirus 2019 (COVID-19) Outbreak: A Perspective of Healthcare Workers.评估也门医疗卫生系统应对 2019 年新型冠状病毒（COVID-19）疫情的能力和准备情况：医疗卫生工作者的观点。
Front Public Health. 2020 Jul 28;8:419. doi: 10.3389/fpubh.2020.00419. eCollection 2020.
5
The Early Stage of COVID-19 Outbreak in Greece: A Review of the National Response and the Socioeconomic Impact.希腊 COVID-19 疫情早期阶段：国家应对措施和社会经济影响综述。
Int J Environ Res Public Health. 2021 Jan 4;18(1):322. doi: 10.3390/ijerph18010322.
6
COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios.瑞典针对非药物缓解和抑制情景的 COVID-19 医疗需求和死亡率。
Int J Epidemiol. 2020 Oct 1;49(5):1443-1453. doi: 10.1093/ije/dyaa121.
7
Impact of COVID-19 outbreak on rheumatic patients' perceptions and behaviors: A cross-sectional study.COVID-19 疫情对风湿患者认知和行为的影响：一项横断面研究。
Int J Rheum Dis. 2020 Nov;23(11):1541-1549. doi: 10.1111/1756-185X.13959. Epub 2020 Sep 17.
8
Understanding South Korea's Response to the COVID-19 Outbreak: A Real-Time Analysis.了解韩国应对 COVID-19 疫情的情况：实时分析。
Int J Environ Res Public Health. 2020 Dec 21;17(24):9571. doi: 10.3390/ijerph17249571.
9
COVID-19 And Racial/Ethnic Disparities In Health Risk, Employment, And Household Composition.新冠疫情与健康风险、就业和家庭构成方面的种族/民族差异。
Health Aff (Millwood). 2020 Sep;39(9):1624-1632. doi: 10.1377/hlthaff.2020.00897. Epub 2020 Jul 14.
10
COVID-19 Pandemic-Related Practices and Policies Affecting the Continuity of Behavioral Health Care Among Children With Diabetes.COVID-19 大流行相关实践和政策对糖尿病患儿行为保健连续性的影响。
Transl Behav Med. 2020 Oct 8;10(4):819-826. doi: 10.1093/tbm/ibaa072.

引用本文的文献

1
Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study.欧洲乌克兰战争难民获得医疗保健及医疗连续性的障碍：RefuHealthAccess研究的结果
Front Public Health. 2025 Apr 2;13:1516161. doi: 10.3389/fpubh.2025.1516161. eCollection 2025.
2
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations.利用数字药物依从性技术提高欧洲卫生系统的可持续性：ENABLE的关键建议。
Lancet Reg Health Eur. 2024 Dec 3;48:101164. doi: 10.1016/j.lanepe.2024.101164. eCollection 2025 Jan.
3
Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLE.跨欧药物依从性管理实施的障碍和未满足的教育需求：COST 行动 ENABLE 的洞察。
J Gen Intern Med. 2024 Nov;39(15):2917-2926. doi: 10.1007/s11606-024-08851-2. Epub 2024 Jun 28.
4
Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland.疫情期间他汀类药物的使用情况：波兰全国真实世界数据中的处方开具、配药、依从性、持续性以及与新冠肺炎统计数据的相关性
Front Pharmacol. 2024 Apr 9;15:1350717. doi: 10.3389/fphar.2024.1350717. eCollection 2024.
5
Effects of COVID-19 on diabetes care among dutch diabetes outpatients.新冠病毒病对荷兰糖尿病门诊患者糖尿病护理的影响。
Diabetol Metab Syndr. 2023 Oct 10;15(1):193. doi: 10.1186/s13098-023-01169-9.
6
COVID-19 pandemic has disrupted the continuity of care for chronic patients: evidence from a cross-sectional retrospective study in a developing country.COVID-19 大流行扰乱了慢性病患者的连续性护理：来自发展中国家的一项横断面回顾性研究的证据。
BMC Prim Care. 2023 Jul 1;24(1):137. doi: 10.1186/s12875-023-02086-6.
7
Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?半个世纪以来对偏离推荐治疗方案的碎片化研究：现在是呼吁建立多学科药物依从性卓越研究中心的好时机吗？
Pharmaceutics. 2023 Mar 14;15(3):933. doi: 10.3390/pharmaceutics15030933.
8
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review.COVID-19 大流行对慢性病治疗依从性的影响：系统评价。
Int J Environ Res Public Health. 2023 Feb 21;20(5):3825. doi: 10.3390/ijerph20053825.
9
Editorial: Recent advances in attempts to improve medication adherence-from basic research to clinical practice.社论：从基础研究到临床实践，提高药物依从性的尝试的最新进展。
Front Pharmacol. 2023 Feb 8;14:1144662. doi: 10.3389/fphar.2023.1144662. eCollection 2023.
10
Working as frontline health facilitators, service providers, program supporters, and social health activists in Indian hilly terrain areas: A qualitative study of accredited social health activists' experiences before and during the COVID-19 pandemic.在印度山区作为一线卫生促进者、服务提供者、项目支持者和社会卫生活动家：在 COVID-19 大流行之前和期间，认证社会卫生活动家的经验的定性研究。
J Glob Health. 2022 Nov 29;12:05052. doi: 10.7189/jogh.12.05052.

本文引用的文献

1
The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review.新型冠状病毒 COVID-19 对非传染性疾病患者和卫生系统的影响：综述。
J Intern Med. 2021 Apr;289(4):450-462. doi: 10.1111/joim.13184. Epub 2020 Oct 27.
2
Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care.COVID-19 对孤独感、心理健康和卫生服务利用的影响：初级保健中老年多病患者的前瞻性队列研究。
Br J Gen Pract. 2020 Oct 29;70(700):e817-e824. doi: 10.3399/bjgp20X713021. Print 2020 Nov.
3
Offline: COVID-19 is not a pandemic.线下：新冠疫情并非大流行。 （此译文可能不符合准确逻辑，因为原句表述不符合客观事实，仅供按照要求翻译。实际新冠疫情是大流行。）
Lancet. 2020 Sep 26;396(10255):874. doi: 10.1016/S0140-6736(20)32000-6.
4
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients.住院前使用他汀类药物与 COVID-19 住院患者严重程度和恢复的关系。
Am J Cardiol. 2020 Dec 1;136:149-155. doi: 10.1016/j.amjcard.2020.09.012. Epub 2020 Sep 16.
5
A wave of non-communicable diseases following the COVID-19 pandemic.新冠疫情之后的一波非传染性疾病。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):979-980. doi: 10.1016/j.dsx.2020.06.050. Epub 2020 Jun 26.
6
Twin epidemics of covid-19 and non-communicable disease.新冠疫情与非传染性疾病的双重流行。
BMJ. 2020 Jun 30;369:m2618. doi: 10.1136/bmj.m2618.
7
Prevention and control of non-communicable diseases in the COVID-19 response.在应对2019冠状病毒病过程中对非传染性疾病的预防与控制
Lancet. 2020 May 30;395(10238):1678-1680. doi: 10.1016/S0140-6736(20)31067-9. Epub 2020 May 10.
8
Non-communicable disease management in vulnerable patients during Covid-19.新冠疫情期间脆弱患者的非传染性疾病管理
Indian J Med Ethics. 2020 Apr-Jun;V(2):103-105. doi: 10.20529/IJME.2020.041.